What StudyKIK does

StudyKIK (legal entity: Caerus Marketing Group, LLC) is a full-service patient recruitment and retention technology company serving the clinical trial industry. Founded in 2013 and acquired by Syneos Health (a global CRO), StudyKIK operates as a Syneos Health Company headquartered in Costa Mesa, California, with 101–250 employees. The company runs an enterprise field sales motion to pharmaceutical sponsors while providing a self-serve platform to clinical trial sites, and a direct-to-consumer patient discovery experience on studykik.com.

The platform is modular and centers on the KIKsite site portal for tracking patient progress, managing email/text/video communications, IRB ad creation, and media source tracking. Sponsor-facing modules include Study Websites (with multilingual capabilities and a 24/7 global call center), eConsent (electronic informed consent powered by DocuSign, compliant with ESIGN, UETA, HIPAA, and Title 21 CFR Part 11), Study Companion Apps (eDiary, ePRO, medication reminders, in-app video visits, Uber Health integration, patient payments), Trial Reporting (central study dashboard aggregating recruitment, consent, randomization, and retention data), and CarePackage (end-to-end patient experience platform). Virtual Visits enable live video appointments from any smart device without additional software. The company also offers Enrollment Plans — quote-based, per-study patient referrals tailored to site budgets and enrollment goals.

StudyKIK generates revenue through technology platform subscriptions and per-study service agreements with sponsors and sites, on a subscription/recurring basis with quote-based pricing rather than publicly listed tiers. Named sponsor logos displayed on the patient-facing site include Genentech, Merck, Exact Sciences, and Ingeneron. The company is privately held, with no disclosed VC/PE backing beyond a 2018 Kinderhook Industries event, and operates without a public ticker.

Name

StudyKIK

Legal name

Caerus Marketing Group, LLC

Website

https://studykik.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

StudyKIK is a clinical trial patient recruitment and retention technology company serving pharmaceutical sponsors, clinical trial sites, and patients. Its modular platform spans eConsent (DocuSign-powered), companion apps, virtual visits, and central reporting, operating as a subsidiary of CRO Syneos Health.

Ownership category

akta.pro rank

Product category

Clinical Trial Patient Recruitment & Retention Software

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)

akta.pro secondary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical trial recruitment
• Patient retention software
• EConsent platform
• Clinical trial technology
• Patient engagement apps

Headquarters

HQ city

Costa Mesa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Technology Platform Subscriptions: StudyKIK provides a technology platform for clinical trial patient recruitment and retention. The platform includes site tools (KIKsite portal), sponsor solutions (eConsent, study websites, apps, reporting), and patient-facing services. Revenue is generated through service agreements with clinical trial sites and sponsors, likely on a subscription or per-study basis.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

StudyKIK provides a cloud-based patient recruitment and retention technology platform for clinical trials, connecting pharmaceutical sponsors, research sites, and patients. Its core offering is the KIKsite site portal complemented by sponsor-side tools including Study Websites, eConsent (powered by DocuSign), Study Companion Apps, Trial Reporting dashboards, Virtual Visits, and the CarePackage patient support platform. The company sells custom-tailored enrollment plans and recruitment services to clinical trial sites and sponsors.

Product overview

StudyKIK is a full-service patient recruitment and retention technology company offering an integrated platform with a modular architecture. The core offering centers on the KIKsite Platform for sites to manage patient recruitment, tracking, and communications, complemented by sponsor-facing solutions including Study Websites, eConsent (powered by DocuSign), Study Companion Apps, Trial Reporting, and CarePackage. Additional services include Virtual Visits for remote trial participation and custom Enrollment Plans. The platform connects clinical trial sponsors, research sites, and patients to accelerate enrollment timelines.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Recruitment Custom-tailored patient recruitment service helping clinical trial sites start recruiting qualified patients in as little as 24 hours with no long-term contracts; designed for clinical research sites that need to fill enrollment quotas.
• KIKsite Platform All-in-one site portal for clinical trial sites that tracks patient progress, manages communications via email/text/video, supports direct scheduling, IRB ad creation, patient database management, and media source tracking with real-time analytics.
• Virtual Visits Live video visit capability enabling clinical trial sites to conduct remote appointments from any smart device without additional software, available 24 hours a day, designed to improve accessibility and reduce patient and site burden.
• Study Websites Custom-made, mobile-friendly clinical trial websites that educate potential participants about a study and accelerate enrollment, with multilingual content, global call center support, and Google Analytics reporting.
• eConsent Electronic informed consent platform developed with real patients and sites that lets patients review and sign consent documents digitally using interactive multimedia, video chat, and live note collaboration; powered by DocuSign and compliant with ESIGN, UETA, HIPAA and Title 21 CFR Part 11.
• Study Companion Apps Custom-tailored mobile apps for clinical trial patients that include eDiary, ePRO, medication reminders, in-app video visits, surveys, achievements, Uber Health transportation integration, and patient payment integration to improve engagement and retention.
• Trial Reporting Central study dashboard that aggregates recruitment, consent, randomization, and retention data across multiple sites, giving sponsors real-time enrollment tracking and site performance metrics with customized reporting and analytics.
• CarePackage Comprehensive patient support platform designed to enhance every step of the clinical trial journey for sponsors, providing compassionate and connected patient experiences throughout the study.
• Enrollment Plans Budget and enrollment goal-based plans for clinical trial sites that deliver qualified patient referrals, tailored to site needs with no long-term contracts.

Quantifiable outcome

• Start recruiting qualified patients in as little as 24 hours with no long-term contracts
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• DocuSigncoreTechnology or IntegrationStudyKIK's eConsent platform is powered by DocuSign, enabling patients to electronically sign consent documents in full compliance with ESIGN, UETA, HIPAA and Title 21, CFR Part 11 regulations.
• Syneos HealthcoreOthersStudyKIK is owned and operated by Caerus Marketing Group LLC d/b/a StudyKIK, a Syneos Health Company. Syneos Health is a global pharmaceutical solutions organization that provides contract research and commercialization services.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Antidote (formerly TrialReach): Antidote is a digital clinical trial patient recruitment platform connecting sponsors and patients via online matching and outreach. It is a direct competitor to StudyKIK in the same product category with comparable sponsor/site/patient value proposition.
• BBK Worldwide: BBK Worldwide is a long-standing patient recruitment and engagement agency for clinical trials, offering digital and traditional recruitment tactics plus site support. It competes head-to-head with StudyKIK for sponsor recruitment budgets across therapeutic areas.

Emerging players

• Deep 6 AI: Deep 6 AI applies AI to EHR data to identify and match patients to clinical trials. It is an emerging competitor focused on a differentiated AI-driven targeting approach that intersects with StudyKIK's recruitment offering.
• SubjectWell: SubjectWell is a patient recruitment platform that connects clinical trial sponsors with treatment-naive patients via consumer channels. It is an emerging player in the same recruitment category with overlap on direct-to-patient acquisition.

Broad incumbents

• Acurian (PPD/Thermo Fisher): Acurian, part of PPD (now Thermo Fisher), provides patient recruitment and retention services as part of a full-service CRO offering. It is a broad incumbent competing with StudyKIK for sponsor recruitment budgets, but bundled within a much wider CRO portfolio.
• IQVIA: IQVIA is the world's largest CRO with patient recruitment capabilities embedded across its full-service and tech offerings. As a broad incumbent it overlaps with StudyKIK for sponsor budgets and could choose to displace third-party platforms with internal solutions.
• Parexel International: Parexel is a major global CRO with site and patient recruitment capabilities across its clinical trial services portfolio. It competes with StudyKIK indirectly through bundled CRO contracts and could develop or acquire competing recruitment technology.
• Medpace: Medpace is a mid-to-large CRO offering full-service clinical development including site management and patient recruitment. It competes with StudyKIK primarily through its integrated CRO delivery model rather than a standalone recruitment platform.

Others

• Mass General Brigham / Partners HealthCare Clinical Trial Platforms: Large academic medical centers operate proprietary trial-matching platforms (e.g., Partners/i2b2-derived) that compete with StudyKIK for patient identification within their health systems. They are adjacent ecosystem participants rather than direct commercial competitors.
• CenterWatch: CenterWatch is a long-running clinical trial information and patient-recruitment services provider publishing trial listings and operating sponsor-facing services. It is thematically related as a patient-discovery channel but operates at smaller scale and a different business model than StudyKIK.

Market position

Strengths2 records

Weaknesses2 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/studykik
• YouTubeyoutube.com/c/Studykik
• Facebookfacebook.com/StudyKIK
• LinkedInlinkedin.com/company/studykik
• Instagraminstagram.com/studykik

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about StudyKIK